Search - tctmd.com

Displaying 41 - 60 of 116

Sort: Relevancy | Date

Presentation TCT 2019

TCT 47: Five-Year Clinical Outcomes From Randomized Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients With Coronary Artery Disease From ABSORB China Trial

Presenter: Run-Lin Gao

September 25, 2019

Presentation TCT 2019

TCT 46: FANTOM II trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – First Report on Initial 48 Month Outcomes

Presenter: Alexandre Abizaid

September 25, 2019

Presentation TCT 2019

TCT 45: Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting - First Cohort Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry

Presenter: Stefan Verheye

September 25, 2019

News Opinion Off Script TCT 2018

Off Script: Phantom Hearts and the Elusive Nature of Angina

Kwan S. Lee

October 11, 2018

Even With PSP, Bioresorbable Scaffold Falls Short in ABSORB-COMPARE and ABSORB IV Trials

News Conference News TCT 2018

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

Michael O'Riordan

September 25, 2018

Presentation TCT 2017

Impact of PSP in ACS: BVS STEMI First and BVS EXPAND

Presenter: Nick E. J. West, Joanna J. Wykrzykowska, Robert-Jan van Geuns

November 01, 2017

Presentation TCT 2017

Saudi Arabia Presents: A Complex BVS Case

Presenter: Waqar H. Ahmed, Oscar A. Mendiz, Mohammed I Kurdi

November 01, 2017

Presentation TCT 2017

Registry Update: BVS STEMI STRATEGY

Presenter: Stephen G. Ellis, Takeshi Kimura, Alfonso Ielasi

October 31, 2017

News Conference News TCT 2017

Long-term Absorb BVS Data Continue to Disappoint

Michael O'Riordan

October 31, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day Two

Shelley Wood

October 31, 2017

Presentation TCT 2017

DAPT Duration After BVS: Can Evidence-Based Recommendations Be Made?

Presenter: John A. Bittl, Freek W.A. Verheugt, Davide Capodanno

October 30, 2017

Presentation TCT 2017

Topic 1: How Should We Evaluate Technologies in Their Infancy? TAVR, Renal Denervation, BVS, LAA Closure, Mechanical Circulatory Support, and More

Presenter: Robert A. Byrne, Gregg W. Stone, Aaron V. Kaplan

October 30, 2017

Presentation TCT 2017

The Alphabet of Peripheral Vascular Devices: BMS, DES, PTFE, BVS, and Future Scaffolds

Presenter: Michael Guiry, Julie Logan

October 30, 2017

Presentation TCT 2017

Flash Debate #3: Should BVS Scaffolds Be Used Today? No - The Evidence Says So!

Presenter: Jun-Jack Cheng, Kenneth Chin, Jack Wei Chieh Tan

October 29, 2017

Presentation TCT 2017

Flash Debate #3: Should BVS Scaffolds Be Used Today? Yes They Are Quite Safe With the Appropriate Implantation Strategy!

Presenter: Jun-Jack Cheng, Kenneth Chin, Teguh Santoso

October 29, 2017

Presentation TCT 2017

Current Updates on BVS: Asia-Pacific and Worldwide

Presenter: Jun-Jack Cheng, Kenneth Chin, Chiung Jen Wu

October 29, 2017

News Conference News TCT 2016

RIBS VI: Absorb BVS Safe in In-Stent Restenosis but Fails to Best Xience Metallic Stent

Michael O'Riordan

November 08, 2016

News Conference News TCT 2016

RIBS VI：Absorb BVS 支架内再狭窄方面安全，但没有好过 Xience 金属支架

Michael O'Riordan

November 08, 2016

Presentation TCT 2016

Selective or Routine Intracoronary Imaging for BVS Implantation? Pro-Routine!

Presenter: Jonathan M. Hill, Christoph K. Naber, Ricardo A. Costa

November 01, 2016

Presentation TCT 2016

Flash Debate: Selective or Routine Intracoronary Imaging for BVS Implantation? Pro-Selective!

Presenter: Jonathan M. Hill, Christoph K. Naber, Joanna J. Wykrzykowska

November 01, 2016

Advertisement

TCT 47: Five-Year Clinical Outcomes From Randomized Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients With Coronary Artery Disease From ABSORB China Trial

TCT 46: FANTOM II trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – First Report on Initial 48 Month Outcomes

TCT 45: Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting - First Cohort Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry

Off Script: Phantom Hearts and the Elusive Nature of Angina

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

Impact of PSP in ACS: BVS STEMI First and BVS EXPAND

Saudi Arabia Presents: A Complex BVS Case

Registry Update: BVS STEMI STRATEGY

Long-term Absorb BVS Data Continue to Disappoint

Live From Denver: TCT 2017, Day Two

DAPT Duration After BVS: Can Evidence-Based Recommendations Be Made?

Topic 1: How Should We Evaluate Technologies in Their Infancy? TAVR, Renal Denervation, BVS, LAA Closure, Mechanical Circulatory Support, and More

The Alphabet of Peripheral Vascular Devices: BMS, DES, PTFE, BVS, and Future Scaffolds

Flash Debate #3: Should BVS Scaffolds Be Used Today? No - The Evidence Says So!

Flash Debate #3: Should BVS Scaffolds Be Used Today? Yes They Are Quite Safe With the Appropriate Implantation Strategy!

Current Updates on BVS: Asia-Pacific and Worldwide

RIBS VI: Absorb BVS Safe in In-Stent Restenosis but Fails to Best Xience Metallic Stent

RIBS VI：Absorb BVS 支架内再狭窄方面安全，但没有好过 Xience 金属支架

Selective or Routine Intracoronary Imaging for BVS Implantation? Pro-Routine!

Flash Debate: Selective or Routine Intracoronary Imaging for BVS Implantation? Pro-Selective!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content